News

Brexit Update 01/01/2021

The UK has now left the EU, following a transition period that ended on 31 December 2020. This means that EU Trade Marks (EUTMs) and Registered Community Designs (RCDs) no longer offer protection in the UK. Here we explore the mechanisms that are in place to protect these IP rights as well as the other headline Brexit issues. We continue...

Read more

The European Patent Office Boards of Appeal to enforce new rules on hearing attendance.

The European Patent Office Boards of Appeal have announced that from 1 January 2021 they will be able to insist that parties attend an appeal hearing by video conference. At present, appeal hearings can be held by video conference rather than in person, but only if all parties agree. If...

Read more

GJE Partner, Arnie Clarke, leads successful landmark opposition attack of Teva’s key 2030 patent (EP 2 949 335) on behalf of Mylan

Arnie Clarke has recently been involved in the ground-breaking appeal relating to Teva’s key 2030 patent (EP 2 949 335). Acting on behalf of Mylan, in front of the EPO board of appeal 3.3.04, Arnie obtained complete revocation of the patent covering the blockbuster Copaxone product, worth $1.51billion to Teva...

Read more

GJE recognised by Chambers & Partners 2021

We are pleased to be recognised as a leading firm in the 2021 edition of Chambers & Partners. Chambers identifies the best law firms globally through interviews and client feedback. The directory assesses client service, commercial vision and business understanding, along with diligence and value for money. GJE have been...

Read more

GJE noted as ‘one of the most trusted UK IP firms for patent prosecution and portfolio management work in Europe’ 2020

We are pleased to have been noted as ‘one of the most trusted UK IP firms for patent prosecution and portfolio management work in Europe’ and listed as a leading firm in the 2020 edition of Managing IP Stars. Every year, the publication independently researches practices in order to identify...

Read more